Atai Life Sciences N.V. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported loss from operations of $61,319,000 against $5,825,000 a year ago. Net loss of $53,373,000 against $16,957,000 a year ago. Basic and diluted net loss per share of $0.37 against $0.18 a year ago. For the six months, the company reported loss from operations of $57,269,000 against $9,539,000 a year ago. Net loss of $49,329,000 against $1,076,000 a year ago. Basic and diluted net loss per share of $0.38 against nil a year ago.